Sound Wave Therapy Shows Promise for Opioid Detox

Doctors at Rambam Health Care Campus in Israel say a man in his 40s went through opioid withdrawal after a single 20-minute session using a noninvasive brain treatment based on focused sound waves.

The case, described by the hospital as part of an early-stage international trial, is being watched closely by addiction researchers, but it remains experimental and is not an approved medical detox option in the United States or anywhere else.

The patient, identified only as H., had developed a dependence on opioid painkillers following a neck injury years earlier, eventually taking about 130 pills a day even after his physical pain had resolved.

He underwent the procedure at Rambam’s painkiller withdrawal clinic roughly two weeks before the case was reported, and follow-up testing found no opioids or other substances in his system a week later.

How the Treatment Works

The technology, developed by the Israeli company Insightec, uses focused sound waves guided by MRI imaging to modulate electrical activity in the nucleus accumbens, a brain region central to reward and craving.

Unlike related focused-ultrasound treatments already used for tremor disorders, this application does not heat or destroy tissue. Instead, doctors say it can increase or suppress nerve cell activity in a targeted area without invasive surgery.

Dr. Amir Minerbi, director of Rambam’s Institute for Pain Medicine, said the patient no longer needed opioids to manage pain but had become dependent on the substance itself to feel functional.

Dr. Lior Lev Tov, who led the study, said the patient reported his craving dropped to zero within days and that he also noticed a sharp drop in his desire to smoke cigarettes and no urge to drink alcohol, effects the research team called unexpected.

The case is part of a small multicenter trial that includes sites in the United States, according to Rambam. Some participants in the broader study were being treated for dependence on heroin, a substance from which withdrawal can extend over a period of years. This particular patient was reportedly the first in the trial to undergo the treatment while in active withdrawal.

Why This Remains Trial Only

One documented patient, however promising, is not clinical evidence that a treatment works broadly, is safe across different patients and substance histories, or will ever receive regulatory approval.

Detox.com does not endorse this treatment, and no one experiencing opioid dependence should treat focused ultrasound as an available or accessible alternative to established medical detox and medication-assisted treatment (MAT).

The two current evidence-based approaches to opioid withdrawal remain gradual dose reduction and the use of substitute medications, such as buprenorphine or methadone, that act on the same brain systems opioids do.

Both approaches are used under medical supervision because opioid withdrawal, while rarely life-threatening on its own the way alcohol or benzodiazepine withdrawal can be, still carries real risks and is often severe enough that unsupervised attempts frequently fail.

Researchers involved in the study said they hope the approach, if validated in larger trials, could eventually complement existing options for opioid use disorder and possibly extend to other conditions involving craving and impulse control, including PTSD and eating disorders. That work is still years away from clinical availability in the US, if it succeeds at all.

Medical Detox Remains the Safe Standard

For anyone in the United States dealing with opioid dependence right now, medical detox conducted under professional supervision remains the established, evidence-based path.

Programs combine withdrawal management with counseling and, where appropriate, MAT medications that reduce cravings and lower the risk of relapse and overdose during early recovery.

You can search detox.com’s directory to find verified detox facilities near you. Call 800-996-6135(Sponsored) to speak with a treatment specialist today.